Expense Reduction. The Parties agree to cooperate during the Research Program Term in identifying and implementing opportunities to reduce the costs incurred in the conduct of the Research Program, including costs of equipment, consumables such as laboratory supplies and Third Party services such as toxicology, clinical studies or manufacturing services, provided such cooperation does not unduly delay or hamper NGM in the performance of its activities thereunder. These attempts may include exploration of Merck’s preferred supply arrangements, and Merck’s procurement expertise.
Appears in 2 contracts
Sources: Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc), Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)